Patent assignee · US · COMPANY

ViaCyte, Inc.

🏢 View company profile →
109Patents
108Active
109Granted
58Portfolio score

Filing activity: Apr 26, 2005 → Mar 22, 2023 · 43 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8187878B2 Methods for increasing definitive endoderm differentiation of pluripotent human embryonic stem cells with PI-3 kinase inhibitors Chemistry; Metallurgy 113 Expired
US7993920B2 Methods of producing pancreatic hormones Chemistry; Metallurgy 102 Active
US8278106B2 Encapsulation of pancreatic cells derived from human pluripotent stem cells Chemistry; Metallurgy 100 Active
US8859286B2 In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells Chemistry; Metallurgy 80 Active
US8129182B2 Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production Chemistry; Metallurgy 73 Active
US8008075B2 Stem cell aggregate suspension compositions and methods of differentiation thereof Chemistry; Metallurgy 67 Active
US7985585B2 Preprimitive streak and mesendoderm cells Chemistry; Metallurgy 62 Active
US8338170B2 Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells Chemistry; Metallurgy 59 Active
US8211699B2 Methods for culturing pluripotent stem cells in suspension using ERBB3 ligands Chemistry; Metallurgy 58 Active
US8334138B2 Methods and compositions for feeder-free pluripotent stem cell media containing human serum Chemistry; Metallurgy 57 Active
US8153429B2 Compositions and methods useful for culturing differentiable cells Chemistry; Metallurgy 53 Active
US8216836B2 Methods for identifying factors for differentiating definitive endoderm Chemistry; Metallurgy 53 Active
US7993916B2 Methods for increasing definitive endoderm production Chemistry; Metallurgy 52 Active
US8623645B2 Definitive endoderm Chemistry; Metallurgy 49 Active
US8647873B2 PDX1 expressing endoderm Chemistry; Metallurgy 49 Active
US9109245B2 Cell compositions derived from dedifferentiated reprogrammed cells Chemistry; Metallurgy 47 Active
US8633024B2 PDX1 expressing endoderm Chemistry; Metallurgy 45 Active
US8658151B2 Expansion of definitive endoderm cells Chemistry; Metallurgy 43 Active
US8586357B2 Markers of definitive endoderm Chemistry; Metallurgy 40 Active
US8603811B2 Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production Chemistry; Metallurgy 37 Active
US8445273B2 Stem cell aggregate suspension compositions and methods of differentiation thereof Chemistry; Metallurgy 34 Active
US8685726B2 Small molecules supporting pluripotent cell growth and methods thereof Chemistry; Metallurgy 30 Active
US8425928B2 Encapsulation of pancreatic cells derived from human pluripotent stem cells Chemistry; Metallurgy 28 Active
US8895300B2 Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof Chemistry; Metallurgy 27 Active
US9365830B2 Agents and methods for inhibiting human pluripotent stem cell growth Chemistry; Metallurgy 26 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.